FAFTFSNP
NBIX icon

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)’s Neurocrine Biosciences NBIX Stock Holding History

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$6.86M Buy
+49,823
New +$6.83M 0.08% 241

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s NBIX Position: Q2 2024 in Review

Fjarde AP-fonden (The Fourth Swedish National Pensionfund) opened a new position in Neurocrine Biosciences (NBIX) in Q2 2024: 49,823 shares worth $6.86M. The stake represents 0.08% of the portfolio and ranks #241 among its holdings.

595 funds tracked by Wall St. Rank hold NBIX as of Q2 2024.

  • Fjarde AP-fonden (The Fourth Swedish National Pensionfund) held 49,823 shares of Neurocrine Biosciences worth $6.86M as of Q2 2024.
  • Neurocrine Biosciences was a new Fjarde AP-fonden (The Fourth Swedish National Pensionfund) position in Q2 2024.
  • Neurocrine Biosciences made up 0.08% of Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s portfolio in Q2 2024, its #241 holding.
  • 595 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2024.

Based on Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s 13F filing for Q2 2024, filed 2 Aug 2024.